Table 2. . Appraisal committee meetings.

Technology	Category (rare/control)	Number of ACMs	Mean time between ACM1 and ACM2 (days)
Sapropterin	Rare	3	64
Secukinumab	Control	2	65
Avacopan	Rare	2	63
Filgotinib	Control	1	–
Risdiplam	Rare	2	63
Empagliflozin	Control	1	–
Ravulizumab	Rare	1	–
Inclisiran	Control	1	–
Mexiletine	Rare	2	345
Dapagliflozin	Control	2	62
Crizanlizumab	Rare	2	252
Fremanezumab	Control	1	–

ACM: Appraisal committee meeting.